newsfilter
← Latest News
PR Newswire·

Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)

  • Xodus Medical has agreed to be acquired by STERIS in a deal announced on October 12, 2026.
  • The acquisition marks a significant milestone in Xodus Medical's 30+ year history, founded in 1993.
  • STERIS operates with approximately $6 billion in revenue \& 18,000 associates globally.
  • Xodus Medical's portfolio complements STERIS by adding operating room consumables \& surgical safety technologies.
  • Xodus Medical is known for its proprietary Pink Pad® patient positioning systems.
  • Craig Kaforey serves as Chief Executive Officer of Xodus Medical.
  • Dan Carestio serves as President \& Chief Executive Officer of STERIS.
  • Goldman Sachs \& Co. LLC acts as exclusive financial advisor to STERIS, while J.P. Morgan serves as exclusive financial advisor to Xodus Medical.
  • Jones Day represents STERIS legally, while Morgan, Lewis & Bockius LLP represents Xodus Medical.